Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events forteo® post market osteosarcoma surveillance program real world data contributes
… 1:25 pm, November 16 Panel: BEST Innovations in Data Infrastructure and Analytic Methods The workshop will be …
… dossiers, preapproval information exchange (PIE), and real-world evidence (RWE). What additional best practices are … dossiers and the new format guidance. Related Services Market Access and Outcomes Strategy Global Value Dossiers and …
… brave, ask questions. They taught me to apply concepts to real-world problems.” “I'm fortunate to work with RTI Health …
… ISPE will address in the next few years. At a time when real-world data is gaining visibility among non-pharmacoepidemiologists, …
… on: July 29, 2024 Contributed by: Emma Hawe, MSc Head, Data Analytics and Design Strategy RTI Health Solutions From … pressure on pharma biostatisticians, epidemiologists, and real-world researchers. There appears to be a highly compressed …
… thought leadership from our experts, and receive periodic news and updates. Fill out the form below to sign up. By choosing to subscribe, you agree to our Data Protection Policy . …
… Spain Learn to Use Target Trial Emulation for Regulatory Real-World Evidence Generation Registration for this event is now … framework in regulatory studies that use real-world data (RWD). We will review tools for causal thinking, such as …
… been selected for the new Medicare Drug Price Negotiation Program and have begun their journey through the process. In 2024, 15 more drugs will be chosen for the program. European Health Technology Assessment Regulation … alter the requirements and procedures for HTAs, market access, and pricing across Europe. Drug developers …
… today as a reference method to detect potential acute post-traumatic complications. There are biomarker tests that … Scientists from RTI Health Solutions and bioMérieux, a world leader in in-vitro diagnostics, conducted research to … GFAP+UCH-L1 or S100B all in one analysis. The research contributes to growing evidence that the biomarker tests may …
… to commercial success. Identifying an unmet need in the market and meeting regulatory requirements is only half of … regulatory pathway and underestimate the reimbursement and market access hurdles that are present. Our experts in market access can help you anticipate, develop, and …